Nov 21, 2017
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Neuren Pharmaceuticals Limited (NURPF) trades on the Other OTC in the Biotechnology industry.
Neuren Pharmaceuticals Limited company overviewThe latest split shown was on November 21, 2017. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 3 splits between December 26, 2007 and November 21, 2017.
Already premium? Sign in